These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13639502)

  • 1. [Obtainment of a strain of Candida utilis relatively resistant to mercury ion; its characteristics].
    GERARDIN C; KAYSER F
    C R Seances Soc Biol Fil; 1958; 152(12):1780-2. PubMed ID: 13639502
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and structural analysis of efficient autonomously replicating sequences (ARSs) of the yeast Candida utilis.
    Iwakiri R; Eguchi S; Noda Y; Adachi H; Yoda K
    Yeast; 2005 Oct; 22(13):1049-60. PubMed ID: 16200505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of promoters suitable for a multidrug-resistant marker CuYAP1 in the yeast Candida utilis.
    Iwakiri R; Noda Y; Adachi H; Yoda K
    Yeast; 2006 Jan; 23(1):23-34. PubMed ID: 16411162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced intracellular glutathione synthesis and excretion capability of Candida utilis by using a low pH-stress strategy.
    Nie W; Wei G; Du G; Li Y; Chen J
    Lett Appl Microbiol; 2005; 40(5):378-84. PubMed ID: 15836743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of chromium biosorption by UV-HNO(2) cooperative mutagenesis in Candida utilis.
    Yin H; He B; Lu X; Peng H; Ye J; Yang F
    Water Res; 2008 Aug; 42(14):3981-9. PubMed ID: 18678388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional purification of the monocarboxylate transporter of the yeast Candida utilis.
    Baltazar F; Cássio F; Leão C
    Biotechnol Lett; 2006 Aug; 28(16):1221-6. PubMed ID: 16802097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma membrane alteration is an early signaling event in doxorubicin-induced apoptosis in the yeast Candida utilis.
    Keyhani E; Keyhani J
    Ann N Y Acad Sci; 2004 Dec; 1030():369-76. PubMed ID: 15659819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells of Candida utilis for in vitro (R)-phenylacetylcarbinol production in an aqueous/octanol two-phase reactor.
    Rosche B; Breuer M; Hauer B; Rogers PL
    Biotechnol Lett; 2005 Apr; 27(8):575-81. PubMed ID: 15973492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cr(VI) reduction in a chromate-resistant strain of Candida maltosa isolated from the leather industry.
    Ramírez-Ramírez R; Calvo-Méndez C; Avila-Rodríguez M; Lappe P; Ulloa M; Vázquez-Juárez R; Gutiérrez-Corona JF
    Antonie Van Leeuwenhoek; 2004 Jan; 85(1):63-8. PubMed ID: 15028877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Candida fabianii as a cause of lethal septicaemia.
    Valenza G; Valenza R; Brederlau J; Frosch M; Kurzai O
    Mycoses; 2006 Jul; 49(4):331-4. PubMed ID: 16784449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced glutathione production by using low-pH stress coupled with cysteine addition in the treatment of high cell density culture of Candida utilis.
    Liang G; Du G; Chen J
    Lett Appl Microbiol; 2008 May; 46(5):507-12. PubMed ID: 18363652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of living candida utilis cells by enzymes of micromonospora.
    Monreal J; Reese DT
    Arch Biochem Biophys; 1968 Sep; 126(3):960-2. PubMed ID: 5686607
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
    Nawrot U; Nowicka J; Juszczak K; Gusin B
    Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
    Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
    Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new strategy to enhance glutathione production by multiple H2O2 induced oxidative stresses in Candida utilis.
    Liang G; Liao X; Du G; Chen J
    Bioresour Technol; 2009 Jan; 100(1):350-5. PubMed ID: 18650087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
    Citak S; Ozçelik B; Cesur S; Abbasoğlu U
    Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y; Chen L; Li C
    J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.